Please use this identifier to cite or link to this item:
http://hdl.handle.net/10603/598693
Title: | Development and evaluation of nanostructured lipid carrier for targeted delivery of gefitinib in breast cancer |
Researcher: | Kumar, Pankaj |
Guide(s): | Aggarwal, Geeta |
Keywords: | Life Sciences Microbiology |
University: | Delhi Pharmaceutical Sciences and Research University (DPSRU) |
Completed Date: | 2024 |
Abstract: | Breast cancer is the most frequently occurring cancer in women and newlinestands as the second-leading cause of female mortality. Gefitinib is a tyrosine kinase newlineinhibitor (TKI) which inhibits the activity of epidermal growth factor receptor newline(EGFR) in breast cancer. |
Pagination: | 120 |
URI: | http://hdl.handle.net/10603/598693 |
Appears in Departments: | Pharmaceutics |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
01_title.pdf | Attached File | 20.89 kB | Adobe PDF | View/Open |
02_preliminary.pdf | 3.39 MB | Adobe PDF | View/Open | |
03_contents.pdf | 309.12 kB | Adobe PDF | View/Open | |
04_abstract.pdf | 188.79 kB | Adobe PDF | View/Open | |
05_chapter 1.pdf | 746.67 kB | Adobe PDF | View/Open | |
06_chapter 2 (1).pdf | 332.34 kB | Adobe PDF | View/Open | |
07_chapter 3.pdf | 580.87 kB | Adobe PDF | View/Open | |
08_chapter 4.pdf | 600.04 kB | Adobe PDF | View/Open | |
09_chapter 5.pdf | 1.25 MB | Adobe PDF | View/Open | |
10_chapter 6.pdf | 448.8 kB | Adobe PDF | View/Open | |
11_chapter 7.pdf | 609.75 kB | Adobe PDF | View/Open | |
12_chapter 8.pdf | 3.23 MB | Adobe PDF | View/Open | |
80_recommendation.pdf | 143.71 kB | Adobe PDF | View/Open | |
annexure.pdf.pdf | 7.17 kB | Adobe PDF | View/Open |
Items in Shodhganga are licensed under Creative Commons Licence Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0).
Altmetric Badge: